Literature DB >> 10199331

Current treatment of oligodendrogliomas.

J R Perry1, D N Louis, J G Cairncross.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10199331     DOI： 10.1001/archneur.56.4.434

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  14 in total

1.  Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique.

Authors:  H E Miettinen; N Paunu; I Rantala; H Kalimo; L Paljärvi; H Helin; H Haapasalo
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

2.  Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas.

Authors:  Abderrahmane Hamlat; Stephan Saikali; Jacques Chaperon; Beatrice Carsin-Nicol; Michéle Le Calve; Thierry Lesimple; Mohamed Ben-hassel; Yvon Guegan
Journal:  J Neurooncol       Date:  2006-09       Impact factor: 4.130

3.  Cisplatin and BCNU chemotherapy for anaplastic oligoastrocytomas.

Authors:  A Boiardi; M Eoli; A Salmaggi; B Pollo; I Milanesi; G Broggi; A Silvani
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

4.  Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma.

Authors:  K Peterson; G Harsh; P G Fisher; J Adler; Q Le
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

5.  Salvage chemotherapy with CPT-11 for recurrent oligodendrogliomas.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

6.  Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.

Authors:  Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

7.  Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.

Authors:  Gurpreet S Kapoor; Timothy A Gocke; Sanjeev Chawla; Robert G Whitmore; Ali Nabavizadeh; Jaroslaw Krejza; Joanna Lopinto; Justin Plaum; Eileen Maloney-Wilensky; Harish Poptani; Elias R Melhem; Kevin D Judy; Donald M O'Rourke
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

8.  Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma.

Authors:  Susan M Chang; Sarah Nelson; Scott Vandenberg; Soonmee Cha; Michael Prados; Nicholas Butowski; Michael McDermott; Andrew T Parsa; Manish Aghi; Jennifer Clarke; Mitchel Berger
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

9.  Incidence of and survival from oligodendroglioma in Denmark, 1943-2002.

Authors:  Malene Schjønning Nielsen; Helle Collatz Christensen; Michael Kosteljanetz; Christoffer Johansen
Journal:  Neuro Oncol       Date:  2008-12-09       Impact factor: 12.300

10.  Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours.

Authors:  Z Dong; Jc-S Pang; M H Ng; W S Poon; L Zhou; H-K Ng
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.